The Pharmaceutical Printed Literature Association (PPLA), founded in 2001, advocates for the continued use of printed medication information to protect patient safety and support informed decision-making. We believe that printed literature remains essential to patient engagement, adherence, and risk communication.
PPLA represents companies that print regulated pharmaceutical materials, such as Package Inserts (PIs), Medication Guides (MedGuides), Patient Package Inserts (PPIs), folding cartons, and pressure-sensitive labels. Our membership also includes suppliers of materials and technology critical to this specialized industry.
Over the last 25 years, PPLA has been instrumental in fighting for patient safety. Partnering with government agencies, congressional offices, and academics, PPLA has established understandable and accessible PI and PMI that have armed pharmacists and patients with the information they need to improve patient health outcomes across the country.
Why Print Matters
Printed medication guides help patients, caregivers, and healthcare providers understand how to use prescriptions safely and effectively, covering dosage, side effects, drug interactions, and more. Studies show print supports better compliance. Federal law requires that drug labeling include printed directions and warnings. While we support electronic access as a useful supplement, print must remain a guaranteed option for both patients and providers.
A Specialized Industry
Pharmaceutical printed literature is produced under FDA-mandated Good Manufacturing Practices (cGMP) using miniature folding equipment tailored specifically for drug packaging, not general commercial printing. The content is tightly regulated, requiring precise, high-quality output from trained professionals.
Board Members
President: Dave Joesten, CCL Label
Treasurer: Terry Griffis, DSP
Russ Haraf, Nosco
Rich Murach, Twin Rivers Paper
Tiffany Overstreet, MM Packaging
Sue Steller, Flottman Company
Andrew Vale, Platinum Press